top newsConfidence External2 min read2h ago
An unloved health-care stock gets a welcome nod in this AI-obsessed market
CNBCNewswireWednesday, May 13, 2026
Desk Brief
Leerink analysts lifted J&J shares to a buy equivalent from hold on Wednesday, citing the company's slate of new drugs.
Leerink analysts lifted J&J shares to a buy equivalent from hold on Wednesday, citing the company's slate of new drugs.
Note Signals
Confidence
External
Quality
--
Sources
--
Tickers
--
Leerink analysts lifted J&J shares to a buy equivalent from hold on Wednesday, citing the company's slate of new drugs.
This article is sourced from CNBC. For the complete story, analysis, and additional context, read the full article.